Literature DB >> 30073123

Role of nitric oxide-scavenging activity of Karanjin and Pongapin in the treatment of Psoriasis.

Anindita Ghosh1, Gopal J Tiwari2.   

Abstract

In the present study, Karanjin and Pongapin, two important furanoflavone, constituents of Pongamia pinnata were studied in the management of Psoriasis. Presently, we have experimentally studied the free radical quenching property of Karanjin and Pongapin. A modified method was used to estimate the scavenging effect of the Karanjin (the highest activity of 95.60%) and Pongapin (68.05%) compared to the ascorbic acid as standard (11.60%) against nitric oxide. Furthermore, Molecular docking studies were performed using CLC drug discovery workbench software version 3.0 of the studied flavones (Karanjin and Pongapin) with the receptors responsible for psoriasis (viz. IL-17A, IL-17F, IL-23, RORγt, and TLR-7). Docking scores of Karanjin and Pongapin with different studied receptors were found to be comparable to that of Methotrexate, a known drug for treating Psoriasis. Docking results suggest that Karanjin and Pongapin might also help in controlling the disease. Overall, our results indicate that flavones (Karanjin and Pongapin) could be a natural and better alternative in curing psoriasis without any side effects.

Entities:  

Keywords:  Flavones; Methotrexate; Nitric oxide; Psoriasis

Year:  2018        PMID: 30073123      PMCID: PMC6060223          DOI: 10.1007/s13205-018-1337-5

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


  11 in total

1.  Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors.

Authors:  Michel Gilliet; Curdin Conrad; Michael Geiges; Antonio Cozzio; Wolfgang Thürlimann; Günter Burg; Frank O Nestle; Reinhard Dummer
Journal:  Arch Dermatol       Date:  2004-12

2.  Empirical scoring functions for advanced protein-ligand docking with PLANTS.

Authors:  Oliver Korb; Thomas Stützle; Thomas E Exner
Journal:  J Chem Inf Model       Date:  2009-01       Impact factor: 4.956

3.  Antioxidant action of Ginkgo biloba extract EGb 761.

Authors:  L Marcocci; L Packer; M T Droy-Lefaix; A Sekaki; M Gardès-Albert
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

4.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

Authors:  L C Green; D A Wagner; J Glogowski; P L Skipper; J S Wishnok; S R Tannenbaum
Journal:  Anal Biochem       Date:  1982-10       Impact factor: 3.365

Review 5.  Nitric oxide in human skin: current status and future prospects.

Authors:  D Bruch-Gerharz; T Ruzicka; V Kolb-Bachofen
Journal:  J Invest Dermatol       Date:  1998-01       Impact factor: 8.551

Review 6.  The IL-23/Th17 axis in the immunopathogenesis of psoriasis.

Authors:  Antonella Di Cesare; Paola Di Meglio; Frank O Nestle
Journal:  J Invest Dermatol       Date:  2009-03-26       Impact factor: 8.551

7.  Nitric oxide: an important articular free radical.

Authors:  G A Murrell; M M Doland; D Jang; C Szabo; R F Warren; J A Hannafin
Journal:  J Bone Joint Surg Am       Date:  1996-02       Impact factor: 5.284

8.  Nitric oxide levels in patients with psoriasis treated with methotrexate.

Authors:  Nilgun Solak Tekin; Nilsel Ilter; Banu Sancak; Muge Guler Ozden; Mehmet Ali Gurer
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

9.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.

Authors:  Claire L Langrish; Yi Chen; Wendy M Blumenschein; Jeanine Mattson; Beth Basham; Jonathan D Sedgwick; Terrill McClanahan; Robert A Kastelein; Daniel J Cua
Journal:  J Exp Med       Date:  2005-01-17       Impact factor: 14.307

Review 10.  Small molecule inhibitors of RORγt: targeting Th17 cells and other applications.

Authors:  Jun R Huh; Dan R Littman
Journal:  Eur J Immunol       Date:  2012-09       Impact factor: 5.532

View more
  2 in total

1.  Ethosomes-based gel formulation of karanjin for treatment of acne vulgaris: in vitro investigations and preclinical assessment.

Authors:  Sartaj Akhtar Ansari; Abdul Qadir; Musarrat Husain Warsi; Mohd Mujeeb; Mohd Aqil; Showkat Rasool Mir; Sanchit Sharma
Journal:  3 Biotech       Date:  2021-10-07       Impact factor: 2.406

2.  Natural product topical therapy in mitigating imiquimod-induced psoriasis-like skin inflammation-underscoring the anti-psoriatic potential of Nimbolide.

Authors:  Nilesh Barku More; Nivya Sharma; Gauthami Pulivendala; Swarna Bale; Chandraiah Godugu
Journal:  Indian J Pharmacol       Date:  2021 Jul-Aug       Impact factor: 1.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.